Realme GT Neo2, GT, and Narzo 50 5G get Android 13 beta
Realme is rolling out Android 13-based Realme UI 3.0 for the Realme GT Neo2, Realme GT 5G, and Realme Narzo 50 5G.
Source: gizchina.com
📰 Trial Version News
Page 3 - Trial Version News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trial Version. Real-time updates on events, politics, business and more.
Realme GT Neo2, GT, and Narzo 50 get Android 13 betas
The company is expanding its rollouts further than before.
Source: gsmarena.com
Realme UI 3.0 Early Access beta reaches Realme GT Neo 3T
Realme is rolling out the Realme UI 3.0 Early Access update for the Realme GT Neo 3T. Realme 9i also gets the update.
Source: gizchina.com
How to play FIFA 23 early
Here's how to get the 10-hour trial version of the game now.
Source: gamepur.com
Realme UI 3.0 beta reaches the Realme Narzo 30 Pro
Realme is expanding the Realme UI 3.0 Open Beta update program for the Realme Narzo 30 Pro 5G that brings Android 12.
Source: gizchina.com
Android 12-based ColorOS 12 is coming to more Oppo smartphones: Check details
Oppo announces Android 12-based ColorOS 12 updates for more phones: Check details
Source: bgr.in
How To Read Articles Behind A Paywall
In many instances, popular online publications such as The Wall Street Journal and The New York Times have their articles hidden behind a paywall.
Source: technewstoday.com
Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong
Ascletis Pharma Inc. (HKEX: 1672) today announces that it has submitted the marketing authorization application for ritonavir (100 mg film-coated tablet) in the Hong Kong Special
Hong Kong United Kingdom Hong Kong Special Administrative Region Hong Kong General Jinzij Wu China National Medical Products Administration
Source: medindia.net
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province
/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that the first sale of its ritonavir tablets in Zhejiang Province has been completed. On...
Hong Kong United Kingdom Jinzij Wu China National Medical Products Administration Zhejiang Intl Medicine Co Ltd Hong Kong Stock Exchange
Source: prnewswire.com
Ascletis Submits Marketing Authorization Application For Ritonavir In Hong Kong
(RTTNews) - Ascletis Pharma Inc. (ASCLF.PK) announced that it has submitted marketing authorization application for ritonavir 100 mg film-coated t...
United Kingdom Jinzij Wu Ascletis Pharma Inc Hong Kong Special Administrative Region Treatment Protocol Novel Coronavirus Pneumonia
Source: businessinsider.com